Statin intolerance is real, findings of a new study revealed. A new PCSK9 inhibitor drug was shown effective in reducing LDL cholesterol level in patients who suffer from side effects of statins.
PCSK9 Inhibitor Drug Evolocumab Offers Option To Reduce LDL Cholesterol In Statin Intolerant Patients
Tech Times - 4 Apr 2016 13:41
Statin intolerance is real, findings of a new study revealed. A new PCSK9 inhibitor drug was shown effective in reducing LDL cholesterol level in patients who suffer from side effects of statins.
Share this Article
Recommended